nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—CYP2E1—Dacarbazine—sarcoma	0.106	0.157	CbGbCtD
Iloperidone—CYP2E1—Mitoxantrone—sarcoma	0.0826	0.122	CbGbCtD
Iloperidone—CYP1A2—Dacarbazine—sarcoma	0.0615	0.0907	CbGbCtD
Iloperidone—CYP3A7—Vincristine—sarcoma	0.0589	0.0867	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0589	0.0867	CbGbCtD
Iloperidone—CYP3A4—Thiotepa—sarcoma	0.0582	0.0857	CbGbCtD
Iloperidone—CYP2E1—Etoposide—sarcoma	0.0521	0.0767	CbGbCtD
Iloperidone—CYP3A5—Vincristine—sarcoma	0.0442	0.065	CbGbCtD
Iloperidone—CYP3A5—Etoposide—sarcoma	0.0405	0.0596	CbGbCtD
Iloperidone—CYP1A2—Etoposide—sarcoma	0.0301	0.0444	CbGbCtD
Iloperidone—CYP3A4—Mitoxantrone—sarcoma	0.025	0.0369	CbGbCtD
Iloperidone—HTR1D—meninx—sarcoma	0.0217	0.192	CbGeAlD
Iloperidone—HTR1D—dura mater—sarcoma	0.02	0.176	CbGeAlD
Iloperidone—CYP3A4—Vincristine—sarcoma	0.0172	0.0254	CbGbCtD
Iloperidone—CYP2D6—Doxorubicin—sarcoma	0.0169	0.0249	CbGbCtD
Iloperidone—CYP3A4—Etoposide—sarcoma	0.0158	0.0232	CbGbCtD
Iloperidone—CYP3A4—Doxorubicin—sarcoma	0.0108	0.0159	CbGbCtD
Iloperidone—HTR7—pulmonary artery—sarcoma	0.0068	0.06	CbGeAlD
Iloperidone—HTR2A—pulmonary artery—sarcoma	0.00424	0.0374	CbGeAlD
Iloperidone—HTR2A—hindlimb—sarcoma	0.00257	0.0226	CbGeAlD
Iloperidone—Gefitinib—EGFR—sarcoma	0.00243	1	CrCbGaD
Iloperidone—HTR2A—appendage—sarcoma	0.0022	0.0194	CbGeAlD
Iloperidone—HTR7—endothelium—sarcoma	0.00213	0.0188	CbGeAlD
Iloperidone—SIGMAR1—mammary gland—sarcoma	0.00201	0.0177	CbGeAlD
Iloperidone—DRD4—testis—sarcoma	0.00182	0.0161	CbGeAlD
Iloperidone—SIGMAR1—myometrium—sarcoma	0.00143	0.0126	CbGeAlD
Iloperidone—HTR2A—endothelium—sarcoma	0.00133	0.0117	CbGeAlD
Iloperidone—SIGMAR1—seminal vesicle—sarcoma	0.00129	0.0114	CbGeAlD
Iloperidone—HTR1D—connective tissue—sarcoma	0.00126	0.0112	CbGeAlD
Iloperidone—CYP3A7—liver—sarcoma	0.00118	0.0105	CbGeAlD
Iloperidone—ADRA2C—myometrium—sarcoma	0.00112	0.00988	CbGeAlD
Iloperidone—HTR1A—hematopoietic system—sarcoma	0.00109	0.00966	CbGeAlD
Iloperidone—SIGMAR1—smooth muscle tissue—sarcoma	0.00108	0.00952	CbGeAlD
Iloperidone—HTR7—hematopoietic system—sarcoma	0.00105	0.00923	CbGeAlD
Iloperidone—ADRA2C—seminal vesicle—sarcoma	0.00101	0.00893	CbGeAlD
Iloperidone—ADRA1A—hematopoietic system—sarcoma	0.00101	0.0089	CbGeAlD
Iloperidone—CYP3A7-CYP3A51P—liver—sarcoma	0.00101	0.00889	CbGeAlD
Iloperidone—HTR7—connective tissue—sarcoma	0.00101	0.00889	CbGeAlD
Iloperidone—SIGMAR1—cardiac atrium—sarcoma	0.00093	0.0082	CbGeAlD
Iloperidone—SIGMAR1—uterus—sarcoma	0.000925	0.00816	CbGeAlD
Iloperidone—HTR7—smooth muscle tissue—sarcoma	0.000921	0.00813	CbGeAlD
Iloperidone—HRH1—myometrium—sarcoma	0.00091	0.00803	CbGeAlD
Iloperidone—ADRA2A—myometrium—sarcoma	0.000894	0.00788	CbGeAlD
Iloperidone—CYP1A2—hematopoietic system—sarcoma	0.000834	0.00736	CbGeAlD
Iloperidone—SIGMAR1—tendon—sarcoma	0.00081	0.00715	CbGeAlD
Iloperidone—ADRA2A—seminal vesicle—sarcoma	0.000807	0.00712	CbGeAlD
Iloperidone—CYP3A5—hematopoietic system—sarcoma	0.000805	0.0071	CbGeAlD
Iloperidone—CYP2E1—seminal vesicle—sarcoma	0.00079	0.00697	CbGeAlD
Iloperidone—SIGMAR1—bone marrow—sarcoma	0.000785	0.00693	CbGeAlD
Iloperidone—HRH1—hematopoietic system—sarcoma	0.000781	0.00689	CbGeAlD
Iloperidone—ADRA2A—hematopoietic system—sarcoma	0.000767	0.00677	CbGeAlD
Iloperidone—HRH1—connective tissue—sarcoma	0.000752	0.00664	CbGeAlD
Iloperidone—CYP2E1—hematopoietic system—sarcoma	0.000751	0.00662	CbGeAlD
Iloperidone—ADRA2A—connective tissue—sarcoma	0.000739	0.00652	CbGeAlD
Iloperidone—Amenorrhoea—Doxorubicin—sarcoma	0.000736	0.00359	CcSEcCtD
Iloperidone—HTR2A—embryo—sarcoma	0.000731	0.00645	CbGeAlD
Iloperidone—ADRA2C—cardiac atrium—sarcoma	0.00073	0.00644	CbGeAlD
Iloperidone—ADRA2C—uterus—sarcoma	0.000726	0.00641	CbGeAlD
Iloperidone—Cardiac disorder—Vincristine—sarcoma	0.000718	0.0035	CcSEcCtD
Iloperidone—Gait disturbance—Epirubicin—sarcoma	0.000716	0.00349	CcSEcCtD
Iloperidone—Vision blurred—Thiotepa—sarcoma	0.000715	0.00348	CcSEcCtD
Iloperidone—ADRA1A—lymphoid tissue—sarcoma	0.00071	0.00627	CbGeAlD
Iloperidone—Anaemia—Thiotepa—sarcoma	0.000702	0.00342	CcSEcCtD
Iloperidone—Angiopathy—Vincristine—sarcoma	0.000702	0.00342	CcSEcCtD
Iloperidone—Agitation—Thiotepa—sarcoma	0.000698	0.0034	CcSEcCtD
Iloperidone—Mediastinal disorder—Vincristine—sarcoma	0.000697	0.00339	CcSEcCtD
Iloperidone—Anaemia—Dactinomycin—sarcoma	0.000696	0.00339	CcSEcCtD
Iloperidone—HTR7—tendon—sarcoma	0.000692	0.00611	CbGeAlD
Iloperidone—Dyskinesia—Doxorubicin—sarcoma	0.000688	0.00335	CcSEcCtD
Iloperidone—HRH1—smooth muscle tissue—sarcoma	0.000688	0.00607	CbGeAlD
Iloperidone—Stomatitis—Etoposide—sarcoma	0.00068	0.00331	CcSEcCtD
Iloperidone—Leukopenia—Thiotepa—sarcoma	0.000679	0.00331	CcSEcCtD
Iloperidone—Salivary hypersecretion—Epirubicin—sarcoma	0.000679	0.00331	CcSEcCtD
Iloperidone—Mental disorder—Vincristine—sarcoma	0.000677	0.0033	CcSEcCtD
Iloperidone—Leukopenia—Dactinomycin—sarcoma	0.000674	0.00328	CcSEcCtD
Iloperidone—Arrhythmia—Mitoxantrone—sarcoma	0.000673	0.00328	CcSEcCtD
Iloperidone—SIGMAR1—testis—sarcoma	0.000671	0.00592	CbGeAlD
Iloperidone—Fluid retention—Epirubicin—sarcoma	0.000664	0.00323	CcSEcCtD
Iloperidone—Gait disturbance—Doxorubicin—sarcoma	0.000663	0.00323	CcSEcCtD
Iloperidone—Hepatobiliary disease—Etoposide—sarcoma	0.00066	0.00321	CcSEcCtD
Iloperidone—HTR2A—hematopoietic system—sarcoma	0.000652	0.00576	CbGeAlD
Iloperidone—Myalgia—Thiotepa—sarcoma	0.000646	0.00315	CcSEcCtD
Iloperidone—Arthralgia—Thiotepa—sarcoma	0.000646	0.00315	CcSEcCtD
Iloperidone—Dry eye—Epirubicin—sarcoma	0.000646	0.00315	CcSEcCtD
Iloperidone—Myalgia—Dactinomycin—sarcoma	0.000641	0.00312	CcSEcCtD
Iloperidone—ADRA2C—tendon—sarcoma	0.000636	0.00562	CbGeAlD
Iloperidone—SIGMAR1—liver—sarcoma	0.000634	0.0056	CbGeAlD
Iloperidone—Mouth ulceration—Epirubicin—sarcoma	0.000632	0.00308	CcSEcCtD
Iloperidone—Salivary hypersecretion—Doxorubicin—sarcoma	0.000628	0.00306	CcSEcCtD
Iloperidone—HTR2A—connective tissue—sarcoma	0.000628	0.00554	CbGeAlD
Iloperidone—Confusional state—Thiotepa—sarcoma	0.000625	0.00304	CcSEcCtD
Iloperidone—Anaemia—Vincristine—sarcoma	0.000622	0.00303	CcSEcCtD
Iloperidone—Urinary tract disorder—Etoposide—sarcoma	0.000619	0.00301	CcSEcCtD
Iloperidone—Agitation—Vincristine—sarcoma	0.000619	0.00301	CcSEcCtD
Iloperidone—Vision blurred—Mitoxantrone—sarcoma	0.000618	0.00301	CcSEcCtD
Iloperidone—Infection—Thiotepa—sarcoma	0.000615	0.003	CcSEcCtD
Iloperidone—Oedema—Dactinomycin—sarcoma	0.000615	0.00299	CcSEcCtD
Iloperidone—Fluid retention—Doxorubicin—sarcoma	0.000614	0.00299	CcSEcCtD
Iloperidone—Urethral disorder—Etoposide—sarcoma	0.000614	0.00299	CcSEcCtD
Iloperidone—Infection—Dactinomycin—sarcoma	0.000611	0.00298	CcSEcCtD
Iloperidone—Nervous system disorder—Thiotepa—sarcoma	0.000608	0.00296	CcSEcCtD
Iloperidone—Anaemia—Mitoxantrone—sarcoma	0.000606	0.00295	CcSEcCtD
Iloperidone—Vertigo—Vincristine—sarcoma	0.000605	0.00295	CcSEcCtD
Iloperidone—Tachycardia—Thiotepa—sarcoma	0.000605	0.00294	CcSEcCtD
Iloperidone—CYP3A4—hematopoietic system—sarcoma	0.000604	0.00533	CbGeAlD
Iloperidone—Leukopenia—Vincristine—sarcoma	0.000603	0.00293	CcSEcCtD
Iloperidone—Dry eye—Doxorubicin—sarcoma	0.000598	0.00291	CcSEcCtD
Iloperidone—CYP2D6—hematopoietic system—sarcoma	0.000594	0.00524	CbGeAlD
Iloperidone—Leukopenia—Mitoxantrone—sarcoma	0.000587	0.00286	CcSEcCtD
Iloperidone—Eye disorder—Etoposide—sarcoma	0.000585	0.00285	CcSEcCtD
Iloperidone—Mouth ulceration—Doxorubicin—sarcoma	0.000585	0.00285	CcSEcCtD
Iloperidone—ADRA2A—cardiac atrium—sarcoma	0.000583	0.00514	CbGeAlD
Iloperidone—Cardiac disorder—Etoposide—sarcoma	0.000581	0.00283	CcSEcCtD
Iloperidone—ADRA2A—uterus—sarcoma	0.00058	0.00511	CbGeAlD
Iloperidone—HTR2A—smooth muscle tissue—sarcoma	0.000575	0.00507	CbGeAlD
Iloperidone—HTR7—testis—sarcoma	0.000573	0.00506	CbGeAlD
Iloperidone—Myalgia—Vincristine—sarcoma	0.000573	0.00279	CcSEcCtD
Iloperidone—Angiopathy—Etoposide—sarcoma	0.000568	0.00277	CcSEcCtD
Iloperidone—Mediastinal disorder—Etoposide—sarcoma	0.000565	0.00275	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000564	0.00275	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00056	0.00273	CcSEcCtD
Iloperidone—Arthralgia—Mitoxantrone—sarcoma	0.000558	0.00272	CcSEcCtD
Iloperidone—Myalgia—Mitoxantrone—sarcoma	0.000558	0.00272	CcSEcCtD
Iloperidone—Paraesthesia—Thiotepa—sarcoma	0.000556	0.00271	CcSEcCtD
Iloperidone—Somnolence—Thiotepa—sarcoma	0.000551	0.00268	CcSEcCtD
Iloperidone—Renal failure acute—Epirubicin—sarcoma	0.00055	0.00268	CcSEcCtD
Iloperidone—Oedema—Vincristine—sarcoma	0.000549	0.00268	CcSEcCtD
Iloperidone—Infection—Vincristine—sarcoma	0.000546	0.00266	CcSEcCtD
Iloperidone—DRD2—testis—sarcoma	0.000542	0.00478	CbGeAlD
Iloperidone—HTR7—liver—sarcoma	0.000542	0.00478	CbGeAlD
Iloperidone—Increased appetite—Epirubicin—sarcoma	0.00054	0.00263	CcSEcCtD
Iloperidone—Confusional state—Mitoxantrone—sarcoma	0.000539	0.00263	CcSEcCtD
Iloperidone—Nervous system disorder—Vincristine—sarcoma	0.000539	0.00262	CcSEcCtD
Iloperidone—Oedema—Mitoxantrone—sarcoma	0.000535	0.00261	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Thiotepa—sarcoma	0.000535	0.0026	CcSEcCtD
Iloperidone—Fatigue—Thiotepa—sarcoma	0.000534	0.0026	CcSEcCtD
Iloperidone—Infection—Mitoxantrone—sarcoma	0.000532	0.00259	CcSEcCtD
Iloperidone—Fatigue—Dactinomycin—sarcoma	0.00053	0.00258	CcSEcCtD
Iloperidone—CYP2E1—lymphoid tissue—sarcoma	0.000528	0.00466	CbGeAlD
Iloperidone—ADRA2C—testis—sarcoma	0.000527	0.00465	CbGeAlD
Iloperidone—Muscle spasms—Etoposide—sarcoma	0.000524	0.00255	CcSEcCtD
Iloperidone—ADRA1A—liver—sarcoma	0.000523	0.00461	CbGeAlD
Iloperidone—Tachycardia—Mitoxantrone—sarcoma	0.000522	0.00254	CcSEcCtD
Iloperidone—Cardiac failure—Epirubicin—sarcoma	0.00052	0.00253	CcSEcCtD
Iloperidone—Lethargy—Epirubicin—sarcoma	0.000518	0.00252	CcSEcCtD
Iloperidone—HRH1—tendon—sarcoma	0.000517	0.00456	CbGeAlD
Iloperidone—Hypotension—Vincristine—sarcoma	0.000513	0.0025	CcSEcCtD
Iloperidone—Feeling abnormal—Thiotepa—sarcoma	0.000511	0.00249	CcSEcCtD
Iloperidone—Renal failure acute—Doxorubicin—sarcoma	0.000509	0.00248	CcSEcCtD
Iloperidone—ADRA2A—tendon—sarcoma	0.000508	0.00448	CbGeAlD
Iloperidone—Feeling abnormal—Dactinomycin—sarcoma	0.000507	0.00247	CcSEcCtD
Iloperidone—Anaemia—Etoposide—sarcoma	0.000504	0.00245	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Vincristine—sarcoma	0.000501	0.00244	CcSEcCtD
Iloperidone—Hypotension—Mitoxantrone—sarcoma	0.0005	0.00243	CcSEcCtD
Iloperidone—Increased appetite—Doxorubicin—sarcoma	0.0005	0.00243	CcSEcCtD
Iloperidone—Affect lability—Epirubicin—sarcoma	0.0005	0.00243	CcSEcCtD
Iloperidone—ADRA2C—liver—sarcoma	0.000498	0.0044	CbGeAlD
Iloperidone—CYP2E1—tendon—sarcoma	0.000497	0.00438	CbGeAlD
Iloperidone—Paraesthesia—Vincristine—sarcoma	0.000493	0.0024	CcSEcCtD
Iloperidone—Vertigo—Etoposide—sarcoma	0.00049	0.00239	CcSEcCtD
Iloperidone—Body temperature increased—Thiotepa—sarcoma	0.00049	0.00239	CcSEcCtD
Iloperidone—Leukopenia—Etoposide—sarcoma	0.000488	0.00238	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000487	0.00237	CcSEcCtD
Iloperidone—SIGMAR1—lymph node—sarcoma	0.000486	0.00429	CbGeAlD
Iloperidone—Body temperature increased—Dactinomycin—sarcoma	0.000486	0.00237	CcSEcCtD
Iloperidone—Cardiac failure—Doxorubicin—sarcoma	0.000481	0.00234	CcSEcCtD
Iloperidone—Mood swings—Epirubicin—sarcoma	0.000481	0.00234	CcSEcCtD
Iloperidone—Paraesthesia—Mitoxantrone—sarcoma	0.00048	0.00234	CcSEcCtD
Iloperidone—Lethargy—Doxorubicin—sarcoma	0.000479	0.00233	CcSEcCtD
Iloperidone—Dyspnoea—Mitoxantrone—sarcoma	0.000477	0.00232	CcSEcCtD
Iloperidone—Somnolence—Mitoxantrone—sarcoma	0.000476	0.00232	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Vincristine—sarcoma	0.000474	0.00231	CcSEcCtD
Iloperidone—Fatigue—Vincristine—sarcoma	0.000474	0.00231	CcSEcCtD
Iloperidone—Dehydration—Epirubicin—sarcoma	0.000472	0.0023	CcSEcCtD
Iloperidone—Orthostatic hypotension—Epirubicin—sarcoma	0.000464	0.00226	CcSEcCtD
Iloperidone—Affect lability—Doxorubicin—sarcoma	0.000462	0.00225	CcSEcCtD
Iloperidone—Hypokalaemia—Epirubicin—sarcoma	0.000462	0.00225	CcSEcCtD
Iloperidone—Fatigue—Mitoxantrone—sarcoma	0.000461	0.00225	CcSEcCtD
Iloperidone—Breast disorder—Epirubicin—sarcoma	0.000459	0.00223	CcSEcCtD
Iloperidone—Nasopharyngitis—Epirubicin—sarcoma	0.000454	0.00221	CcSEcCtD
Iloperidone—Gastritis—Epirubicin—sarcoma	0.000449	0.00219	CcSEcCtD
Iloperidone—Confusional state—Etoposide—sarcoma	0.000449	0.00219	CcSEcCtD
Iloperidone—Mood swings—Doxorubicin—sarcoma	0.000445	0.00217	CcSEcCtD
Iloperidone—Asthenia—Thiotepa—sarcoma	0.000445	0.00216	CcSEcCtD
Iloperidone—Infection—Etoposide—sarcoma	0.000442	0.00215	CcSEcCtD
Iloperidone—Asthenia—Dactinomycin—sarcoma	0.000441	0.00215	CcSEcCtD
Iloperidone—Feeling abnormal—Mitoxantrone—sarcoma	0.000441	0.00215	CcSEcCtD
Iloperidone—Asthma—Epirubicin—sarcoma	0.000439	0.00214	CcSEcCtD
Iloperidone—Dehydration—Doxorubicin—sarcoma	0.000437	0.00213	CcSEcCtD
Iloperidone—Tachycardia—Etoposide—sarcoma	0.000434	0.00212	CcSEcCtD
Iloperidone—Body temperature increased—Vincristine—sarcoma	0.000434	0.00212	CcSEcCtD
Iloperidone—CYP1A2—liver—sarcoma	0.000432	0.00381	CbGeAlD
Iloperidone—HTR2A—tendon—sarcoma	0.000432	0.00381	CbGeAlD
Iloperidone—Orthostatic hypotension—Doxorubicin—sarcoma	0.000429	0.00209	CcSEcCtD
Iloperidone—HRH1—testis—sarcoma	0.000428	0.00378	CbGeAlD
Iloperidone—Hypokalaemia—Doxorubicin—sarcoma	0.000427	0.00208	CcSEcCtD
Iloperidone—Breast disorder—Doxorubicin—sarcoma	0.000424	0.00207	CcSEcCtD
Iloperidone—Diarrhoea—Thiotepa—sarcoma	0.000424	0.00206	CcSEcCtD
Iloperidone—Body temperature increased—Mitoxantrone—sarcoma	0.000423	0.00206	CcSEcCtD
Iloperidone—Diarrhoea—Dactinomycin—sarcoma	0.000421	0.00205	CcSEcCtD
Iloperidone—ADRA2A—testis—sarcoma	0.00042	0.00371	CbGeAlD
Iloperidone—Nasopharyngitis—Doxorubicin—sarcoma	0.00042	0.00205	CcSEcCtD
Iloperidone—CYP3A5—liver—sarcoma	0.000417	0.00368	CbGeAlD
Iloperidone—Hypotension—Etoposide—sarcoma	0.000416	0.00203	CcSEcCtD
Iloperidone—Gastritis—Doxorubicin—sarcoma	0.000416	0.00202	CcSEcCtD
Iloperidone—CYP2E1—testis—sarcoma	0.000411	0.00363	CbGeAlD
Iloperidone—Dysuria—Epirubicin—sarcoma	0.00041	0.002	CcSEcCtD
Iloperidone—Dizziness—Thiotepa—sarcoma	0.00041	0.002	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Epirubicin—sarcoma	0.000408	0.00199	CcSEcCtD
Iloperidone—Asthma—Doxorubicin—sarcoma	0.000406	0.00198	CcSEcCtD
Iloperidone—Pollakiuria—Epirubicin—sarcoma	0.000405	0.00197	CcSEcCtD
Iloperidone—Paraesthesia—Etoposide—sarcoma	0.0004	0.00195	CcSEcCtD
Iloperidone—Weight increased—Epirubicin—sarcoma	0.000399	0.00194	CcSEcCtD
Iloperidone—Weight decreased—Epirubicin—sarcoma	0.000397	0.00193	CcSEcCtD
Iloperidone—Dyspnoea—Etoposide—sarcoma	0.000397	0.00193	CcSEcCtD
Iloperidone—Somnolence—Etoposide—sarcoma	0.000396	0.00193	CcSEcCtD
Iloperidone—Asthenia—Vincristine—sarcoma	0.000394	0.00192	CcSEcCtD
Iloperidone—Rash—Thiotepa—sarcoma	0.000391	0.0019	CcSEcCtD
Iloperidone—Dermatitis—Thiotepa—sarcoma	0.00039	0.0019	CcSEcCtD
Iloperidone—CYP2E1—liver—sarcoma	0.000389	0.00343	CbGeAlD
Iloperidone—Rash—Dactinomycin—sarcoma	0.000388	0.00189	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Etoposide—sarcoma	0.000384	0.00187	CcSEcCtD
Iloperidone—Asthenia—Mitoxantrone—sarcoma	0.000384	0.00187	CcSEcCtD
Iloperidone—Fatigue—Etoposide—sarcoma	0.000384	0.00187	CcSEcCtD
Iloperidone—ADRA2C—lymph node—sarcoma	0.000382	0.00337	CbGeAlD
Iloperidone—Stomatitis—Epirubicin—sarcoma	0.000381	0.00186	CcSEcCtD
Iloperidone—Conjunctivitis—Epirubicin—sarcoma	0.00038	0.00185	CcSEcCtD
Iloperidone—Dysuria—Doxorubicin—sarcoma	0.00038	0.00185	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000377	0.00184	CcSEcCtD
Iloperidone—Diarrhoea—Vincristine—sarcoma	0.000376	0.00183	CcSEcCtD
Iloperidone—Pollakiuria—Doxorubicin—sarcoma	0.000375	0.00183	CcSEcCtD
Iloperidone—Hepatobiliary disease—Epirubicin—sarcoma	0.00037	0.0018	CcSEcCtD
Iloperidone—Weight increased—Doxorubicin—sarcoma	0.000369	0.0018	CcSEcCtD
Iloperidone—Epistaxis—Epirubicin—sarcoma	0.000369	0.0018	CcSEcCtD
Iloperidone—Nausea—Thiotepa—sarcoma	0.000368	0.00179	CcSEcCtD
Iloperidone—Weight decreased—Doxorubicin—sarcoma	0.000367	0.00179	CcSEcCtD
Iloperidone—Feeling abnormal—Etoposide—sarcoma	0.000367	0.00179	CcSEcCtD
Iloperidone—Diarrhoea—Mitoxantrone—sarcoma	0.000366	0.00178	CcSEcCtD
Iloperidone—Nausea—Dactinomycin—sarcoma	0.000365	0.00178	CcSEcCtD
Iloperidone—Dizziness—Vincristine—sarcoma	0.000363	0.00177	CcSEcCtD
Iloperidone—HTR2A—testis—sarcoma	0.000358	0.00315	CbGeAlD
Iloperidone—Stomatitis—Doxorubicin—sarcoma	0.000353	0.00172	CcSEcCtD
Iloperidone—Body temperature increased—Etoposide—sarcoma	0.000352	0.00171	CcSEcCtD
Iloperidone—Conjunctivitis—Doxorubicin—sarcoma	0.000352	0.00171	CcSEcCtD
Iloperidone—Urinary tract disorder—Epirubicin—sarcoma	0.000347	0.00169	CcSEcCtD
Iloperidone—Rash—Vincristine—sarcoma	0.000346	0.00169	CcSEcCtD
Iloperidone—Dermatitis—Vincristine—sarcoma	0.000346	0.00169	CcSEcCtD
Iloperidone—Connective tissue disorder—Epirubicin—sarcoma	0.000345	0.00168	CcSEcCtD
Iloperidone—Urethral disorder—Epirubicin—sarcoma	0.000344	0.00168	CcSEcCtD
Iloperidone—Hepatobiliary disease—Doxorubicin—sarcoma	0.000342	0.00167	CcSEcCtD
Iloperidone—Epistaxis—Doxorubicin—sarcoma	0.000341	0.00166	CcSEcCtD
Iloperidone—HTR2A—liver—sarcoma	0.000338	0.00298	CbGeAlD
Iloperidone—Rash—Mitoxantrone—sarcoma	0.000337	0.00164	CcSEcCtD
Iloperidone—Dermatitis—Mitoxantrone—sarcoma	0.000337	0.00164	CcSEcCtD
Iloperidone—Eye disorder—Epirubicin—sarcoma	0.000328	0.0016	CcSEcCtD
Iloperidone—Tinnitus—Epirubicin—sarcoma	0.000327	0.00159	CcSEcCtD
Iloperidone—Nausea—Vincristine—sarcoma	0.000326	0.00159	CcSEcCtD
Iloperidone—Cardiac disorder—Epirubicin—sarcoma	0.000326	0.00159	CcSEcCtD
Iloperidone—CYP2D6—testis—sarcoma	0.000326	0.00287	CbGeAlD
Iloperidone—Urinary tract disorder—Doxorubicin—sarcoma	0.000321	0.00156	CcSEcCtD
Iloperidone—Asthenia—Etoposide—sarcoma	0.000319	0.00156	CcSEcCtD
Iloperidone—Connective tissue disorder—Doxorubicin—sarcoma	0.000319	0.00155	CcSEcCtD
Iloperidone—Angiopathy—Epirubicin—sarcoma	0.000319	0.00155	CcSEcCtD
Iloperidone—Urethral disorder—Doxorubicin—sarcoma	0.000318	0.00155	CcSEcCtD
Iloperidone—Nausea—Mitoxantrone—sarcoma	0.000318	0.00155	CcSEcCtD
Iloperidone—Mediastinal disorder—Epirubicin—sarcoma	0.000316	0.00154	CcSEcCtD
Iloperidone—Arrhythmia—Epirubicin—sarcoma	0.000314	0.00153	CcSEcCtD
Iloperidone—CYP3A4—liver—sarcoma	0.000313	0.00276	CbGeAlD
Iloperidone—HRH1—lymph node—sarcoma	0.00031	0.00274	CbGeAlD
Iloperidone—CYP2D6—liver—sarcoma	0.000308	0.00272	CbGeAlD
Iloperidone—Mental disorder—Epirubicin—sarcoma	0.000308	0.0015	CcSEcCtD
Iloperidone—Malnutrition—Epirubicin—sarcoma	0.000306	0.00149	CcSEcCtD
Iloperidone—ADRA2A—lymph node—sarcoma	0.000305	0.00269	CbGeAlD
Iloperidone—Diarrhoea—Etoposide—sarcoma	0.000304	0.00148	CcSEcCtD
Iloperidone—Eye disorder—Doxorubicin—sarcoma	0.000304	0.00148	CcSEcCtD
Iloperidone—Tinnitus—Doxorubicin—sarcoma	0.000303	0.00148	CcSEcCtD
Iloperidone—Cardiac disorder—Doxorubicin—sarcoma	0.000302	0.00147	CcSEcCtD
Iloperidone—Angiopathy—Doxorubicin—sarcoma	0.000295	0.00144	CcSEcCtD
Iloperidone—Dizziness—Etoposide—sarcoma	0.000294	0.00143	CcSEcCtD
Iloperidone—Muscle spasms—Epirubicin—sarcoma	0.000294	0.00143	CcSEcCtD
Iloperidone—Mediastinal disorder—Doxorubicin—sarcoma	0.000293	0.00143	CcSEcCtD
Iloperidone—Arrhythmia—Doxorubicin—sarcoma	0.00029	0.00141	CcSEcCtD
Iloperidone—Vision blurred—Epirubicin—sarcoma	0.000288	0.0014	CcSEcCtD
Iloperidone—Mental disorder—Doxorubicin—sarcoma	0.000285	0.00139	CcSEcCtD
Iloperidone—Malnutrition—Doxorubicin—sarcoma	0.000283	0.00138	CcSEcCtD
Iloperidone—Anaemia—Epirubicin—sarcoma	0.000283	0.00138	CcSEcCtD
Iloperidone—Agitation—Epirubicin—sarcoma	0.000281	0.00137	CcSEcCtD
Iloperidone—Rash—Etoposide—sarcoma	0.000281	0.00137	CcSEcCtD
Iloperidone—Dermatitis—Etoposide—sarcoma	0.00028	0.00137	CcSEcCtD
Iloperidone—Vertigo—Epirubicin—sarcoma	0.000275	0.00134	CcSEcCtD
Iloperidone—Leukopenia—Epirubicin—sarcoma	0.000274	0.00133	CcSEcCtD
Iloperidone—Muscle spasms—Doxorubicin—sarcoma	0.000272	0.00132	CcSEcCtD
Iloperidone—Palpitations—Epirubicin—sarcoma	0.00027	0.00132	CcSEcCtD
Iloperidone—Vision blurred—Doxorubicin—sarcoma	0.000267	0.0013	CcSEcCtD
Iloperidone—Nausea—Etoposide—sarcoma	0.000264	0.00129	CcSEcCtD
Iloperidone—Anaemia—Doxorubicin—sarcoma	0.000261	0.00127	CcSEcCtD
Iloperidone—Arthralgia—Epirubicin—sarcoma	0.00026	0.00127	CcSEcCtD
Iloperidone—Myalgia—Epirubicin—sarcoma	0.00026	0.00127	CcSEcCtD
Iloperidone—Agitation—Doxorubicin—sarcoma	0.00026	0.00127	CcSEcCtD
Iloperidone—Dry mouth—Epirubicin—sarcoma	0.000254	0.00124	CcSEcCtD
Iloperidone—Vertigo—Doxorubicin—sarcoma	0.000254	0.00124	CcSEcCtD
Iloperidone—Leukopenia—Doxorubicin—sarcoma	0.000253	0.00123	CcSEcCtD
Iloperidone—Confusional state—Epirubicin—sarcoma	0.000252	0.00123	CcSEcCtD
Iloperidone—Palpitations—Doxorubicin—sarcoma	0.00025	0.00122	CcSEcCtD
Iloperidone—Oedema—Epirubicin—sarcoma	0.000249	0.00121	CcSEcCtD
Iloperidone—Infection—Epirubicin—sarcoma	0.000248	0.00121	CcSEcCtD
Iloperidone—Nervous system disorder—Epirubicin—sarcoma	0.000245	0.00119	CcSEcCtD
Iloperidone—Tachycardia—Epirubicin—sarcoma	0.000243	0.00119	CcSEcCtD
Iloperidone—Myalgia—Doxorubicin—sarcoma	0.000241	0.00117	CcSEcCtD
Iloperidone—Arthralgia—Doxorubicin—sarcoma	0.000241	0.00117	CcSEcCtD
Iloperidone—Dry mouth—Doxorubicin—sarcoma	0.000235	0.00115	CcSEcCtD
Iloperidone—Hypotension—Epirubicin—sarcoma	0.000233	0.00114	CcSEcCtD
Iloperidone—Confusional state—Doxorubicin—sarcoma	0.000233	0.00113	CcSEcCtD
Iloperidone—Oedema—Doxorubicin—sarcoma	0.000231	0.00112	CcSEcCtD
Iloperidone—Infection—Doxorubicin—sarcoma	0.000229	0.00112	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000227	0.00111	CcSEcCtD
Iloperidone—Nervous system disorder—Doxorubicin—sarcoma	0.000226	0.0011	CcSEcCtD
Iloperidone—Tachycardia—Doxorubicin—sarcoma	0.000225	0.0011	CcSEcCtD
Iloperidone—Paraesthesia—Epirubicin—sarcoma	0.000224	0.00109	CcSEcCtD
Iloperidone—Dyspnoea—Epirubicin—sarcoma	0.000222	0.00108	CcSEcCtD
Iloperidone—Somnolence—Epirubicin—sarcoma	0.000222	0.00108	CcSEcCtD
Iloperidone—Hypotension—Doxorubicin—sarcoma	0.000216	0.00105	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Epirubicin—sarcoma	0.000215	0.00105	CcSEcCtD
Iloperidone—Fatigue—Epirubicin—sarcoma	0.000215	0.00105	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00021	0.00102	CcSEcCtD
Iloperidone—Paraesthesia—Doxorubicin—sarcoma	0.000207	0.00101	CcSEcCtD
Iloperidone—Dyspnoea—Doxorubicin—sarcoma	0.000206	0.001	CcSEcCtD
Iloperidone—Feeling abnormal—Epirubicin—sarcoma	0.000206	0.001	CcSEcCtD
Iloperidone—Somnolence—Doxorubicin—sarcoma	0.000205	0.000999	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000199	0.000971	CcSEcCtD
Iloperidone—Fatigue—Doxorubicin—sarcoma	0.000199	0.000969	CcSEcCtD
Iloperidone—Body temperature increased—Epirubicin—sarcoma	0.000197	0.00096	CcSEcCtD
Iloperidone—Feeling abnormal—Doxorubicin—sarcoma	0.00019	0.000926	CcSEcCtD
Iloperidone—Body temperature increased—Doxorubicin—sarcoma	0.000182	0.000889	CcSEcCtD
Iloperidone—Asthenia—Epirubicin—sarcoma	0.000179	0.000872	CcSEcCtD
Iloperidone—Diarrhoea—Epirubicin—sarcoma	0.000171	0.000831	CcSEcCtD
Iloperidone—Asthenia—Doxorubicin—sarcoma	0.000166	0.000807	CcSEcCtD
Iloperidone—Dizziness—Epirubicin—sarcoma	0.000165	0.000803	CcSEcCtD
Iloperidone—Diarrhoea—Doxorubicin—sarcoma	0.000158	0.000769	CcSEcCtD
Iloperidone—Rash—Epirubicin—sarcoma	0.000157	0.000766	CcSEcCtD
Iloperidone—Dermatitis—Epirubicin—sarcoma	0.000157	0.000765	CcSEcCtD
Iloperidone—Dizziness—Doxorubicin—sarcoma	0.000153	0.000743	CcSEcCtD
Iloperidone—Nausea—Epirubicin—sarcoma	0.000148	0.000722	CcSEcCtD
Iloperidone—Rash—Doxorubicin—sarcoma	0.000146	0.000709	CcSEcCtD
Iloperidone—Dermatitis—Doxorubicin—sarcoma	0.000145	0.000708	CcSEcCtD
Iloperidone—Nausea—Doxorubicin—sarcoma	0.000137	0.000668	CcSEcCtD
